215 related articles for article (PubMed ID: 14755338)
1. Site and mechanism of leptin action in a rodent form of congenital lipodystrophy.
Asilmaz E; Cohen P; Miyazaki M; Dobrzyn P; Ueki K; Fayzikhodjaeva G; Soukas AA; Kahn CR; Ntambi JM; Socci ND; Friedman JM
J Clin Invest; 2004 Feb; 113(3):414-24. PubMed ID: 14755338
[TBL] [Abstract][Full Text] [Related]
2. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss.
Cohen P; Miyazaki M; Socci ND; Hagge-Greenberg A; Liedtke W; Soukas AA; Sharma R; Hudgins LC; Ntambi JM; Friedman JM
Science; 2002 Jul; 297(5579):240-3. PubMed ID: 12114623
[TBL] [Abstract][Full Text] [Related]
3. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.
Petersen KF; Oral EA; Dufour S; Befroy D; Ariyan C; Yu C; Cline GW; DePaoli AM; Taylor SI; Gorden P; Shulman GI
J Clin Invest; 2002 May; 109(10):1345-50. PubMed ID: 12021250
[TBL] [Abstract][Full Text] [Related]
4. Stearoyl-CoA desaturase-1 and the metabolic syndrome.
Cohen P; Ntambi JM; Friedman JM
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):271-80. PubMed ID: 14683458
[TBL] [Abstract][Full Text] [Related]
5. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice.
Wang Q; Jiang L; Wang J; Li S; Yu Y; You J; Zeng R; Gao X; Rui L; Li W; Liu Y
Hepatology; 2009 Apr; 49(4):1166-75. PubMed ID: 19177596
[TBL] [Abstract][Full Text] [Related]
6. Stearoyl-CoA desaturase--a new player in skeletal muscle metabolism regulation.
Dobrzyń A; Dobrzyń P
J Physiol Pharmacol; 2006 Nov; 57 Suppl 10():31-42. PubMed ID: 17242489
[TBL] [Abstract][Full Text] [Related]
7. Leptin ameliorates insulin resistance and hepatic steatosis in Agpat2-/- lipodystrophic mice independent of hepatocyte leptin receptors.
Cortés VA; Cautivo KM; Rong S; Garg A; Horton JD; Agarwal AK
J Lipid Res; 2014 Feb; 55(2):276-88. PubMed ID: 24293639
[TBL] [Abstract][Full Text] [Related]
8. Leptin activates hepatic 5'-AMP-activated protein kinase through sympathetic nervous system and α1-adrenergic receptor: a potential mechanism for improvement of fatty liver in lipodystrophy by leptin.
Miyamoto L; Ebihara K; Kusakabe T; Aotani D; Yamamoto-Kataoka S; Sakai T; Aizawa-Abe M; Yamamoto Y; Fujikura J; Hayashi T; Hosoda K; Nakao K
J Biol Chem; 2012 Nov; 287(48):40441-7. PubMed ID: 23024365
[TBL] [Abstract][Full Text] [Related]
9. The messenger RNA profiles in liver, hypothalamus, white adipose tissue, and skeletal muscle of female Zucker diabetic fatty rats after topiramate treatment.
Liang Y; She P; Wang X; Demarest K
Metabolism; 2006 Oct; 55(10):1411-9. PubMed ID: 16979414
[TBL] [Abstract][Full Text] [Related]
10. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
11. Tissue-specific effects of central leptin on the expression of genes involved in lipid metabolism in liver and white adipose tissue.
Gallardo N; Bonzón-Kulichenko E; Fernández-Agulló T; Moltó E; Gómez-Alonso S; Blanco P; Carrascosa JM; Ros M; Andrés A
Endocrinology; 2007 Dec; 148(12):5604-10. PubMed ID: 17823267
[TBL] [Abstract][Full Text] [Related]
12. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
13. High doses of stavudine induce fat wasting and mild liver damage without impairing mitochondrial respiration in mice.
Igoudjil A; Abbey-Toby A; Begriche K; Grodet A; Chataigner K; Peytavin G; Maachi M; Colin M; Robin MA; Lettéron P; Feldmann G; Pessayre D; Fromenty B
Antivir Ther; 2007; 12(3):389-400. PubMed ID: 17591029
[TBL] [Abstract][Full Text] [Related]
14. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
15. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.
Shimomura I; Hammer RE; Ikemoto S; Brown MS; Goldstein JL
Nature; 1999 Sep; 401(6748):73-6. PubMed ID: 10485707
[TBL] [Abstract][Full Text] [Related]
16. Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c.
Biddinger SB; Miyazaki M; Boucher J; Ntambi JM; Kahn CR
Diabetes; 2006 Jul; 55(7):2032-41. PubMed ID: 16804073
[TBL] [Abstract][Full Text] [Related]
17. Effects of adiponectin transgenic expression in liver of nonalcoholic steatohepatitis model mice.
Nakayama H; Otabe S; Yuan X; Ueno T; Hirota N; Fukutani T; Wada N; Hashinaga T; Yamada K
Metabolism; 2009 Jul; 58(7):901-8. PubMed ID: 19394977
[TBL] [Abstract][Full Text] [Related]
18. Leptin and the control of metabolism: role for stearoyl-CoA desaturase-1 (SCD-1).
Cohen P; Friedman JM
J Nutr; 2004 Sep; 134(9):2455S-2463S. PubMed ID: 15333742
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of the renin-angiotensin system blockers on nonalcoholic fatty liver disease and insulin resistance in C57BL/6 mice.
Frantz ED; Penna-de-Carvalho A; Batista Tde M; Aguila MB; Mandarim-de-Lacerda CA
Metab Syndr Relat Disord; 2014 May; 12(4):191-201. PubMed ID: 24517411
[TBL] [Abstract][Full Text] [Related]
20. Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance.
Gutiérrez-Juárez R; Pocai A; Mulas C; Ono H; Bhanot S; Monia BP; Rossetti L
J Clin Invest; 2006 Jun; 116(6):1686-95. PubMed ID: 16741579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
